One year in review
One year in review 2016: systemic lupus erythematosus
A. Adinolfi1, E. Valentini2, E. Calabresi3, G. Tesei4, V. Signorini5, S. Barsotti6, C. Tani7
- Department of Rheumatology, Policlinico Le Scotte, University of Siena, Italy. antonella.adinolfi986@gmail.com
- Rheumatology Unit, University of Perugia, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Florence, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa; and Department of Medical Biotechnologies, University of Siena, Italy.
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
CER9539
2016 Vol.34, N°4
PI 0569, PF 0574
One year in review
Free to view
(click on article PDF icon to read the article)
PMID: 27463977 [PubMed]
Received: 28/04/2016
Accepted : 29/04/2016
In Press: 14/07/2016
Published: 14/07/2016
Abstract
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with a highly variable course and prognosis. The management of the disease is still a clinical challenge for the treating physicians as many aspects regarding the disease pathogenesis, clinical picture and outcomes remain to be elucidated. New and interesting data are emerging; here the recent literature on SLE pathogenesis, clinical and laboratory aspects, as well as treatments and comorbidities, are reviewed and the main findings summarised in order to provide a bird’s eye on the relevant papers on these topics.
